Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Holding ELTP?
Track your performance easily

Elite Pharmaceuticals (ELTP) Stock Price & Analysis

227 Followers

ELTP Stock Chart & Stats


Financials

Annual

Ownership Overview

21.53%0.01%78.45%
21.53% Insiders
0.01% Other Institutional Investors
78.45% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

ELTP FAQ

What was Elite Pharmaceuticals’s price range in the past 12 months?
Elite Pharmaceuticals lowest stock price was $0.10 and its highest was $0.75 in the past 12 months.
    What is Elite Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Elite Pharmaceuticals’s upcoming earnings report date?
    Elite Pharmaceuticals’s upcoming earnings report date is Nov 12, 2024 which is in 5 days.
      How were Elite Pharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is Elite Pharmaceuticals overvalued?
      According to Wall Street analysts Elite Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Elite Pharmaceuticals pay dividends?
        Elite Pharmaceuticals does not currently pay dividends.
        What is Elite Pharmaceuticals’s EPS estimate?
        Elite Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Elite Pharmaceuticals have?
        Elite Pharmaceuticals has 1,068,273,100 shares outstanding.
          What happened to Elite Pharmaceuticals’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Elite Pharmaceuticals?
          Among the largest hedge funds holding Elite Pharmaceuticals’s share is Fisher Asset Management LLC. It holds Elite Pharmaceuticals’s shares valued at N/A.
            ---

            Company Description

            Elite Pharmaceuticals

            Elite Pharmaceuticals, Inc. engages in the development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) segments. The ANDA segment includes generic pharmaceuticals. The NDA segment comprises the branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.
            ---

            ELTP Earnings Call

            Q1 2024
            0:00 / 0:00
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Tonix Pharma
            Aytu BioScience
            Citius Pharmaceuticals
            Soligenix
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis